CVD Equipment Corporation (NASDAQ: CVV) today announced that its subsidiary, CVD Materials Corporation (CVDM), will together with Dymax Corporation and Keyence Corporation of America collaborate in an effort to accelerate the development of CVDM’s novel c-VACNT™ Extracorporeal Membrane Oxygenation (ECMO) platform. ECMO devices are used to add Oxygen and remove Carbon Dioxide from a blood stream during periods when the patient’s lungs are not performing at appropriate levels. Typically, they are used during heart / lung surgery, but have recently been used as a last resort for recovery from COVID-19 illness.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]